Hospitals under pressure? This surgery-center chain is up 40.8% since April By Investing.com RSS CTA

Tenet Healthcare (NYSE:THC), which operates hospitals and surgery centers, reported a 40.8% stock increase since April. Its Q3 adjusted EPS beat estimates by 42%, with revenue up 6.5% YoY. Management raised full-year EBITDA guidance. The company benefits from a shift to higher-margin outpatient surgeries, with strong cash flow and reduced debt.

Original reporting
Published Nov 5, 2026, 7:57 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 8:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$THC
Bullish
high confidence
Mentioned
$THC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$THCBullishHigh
01

Why it matters

The earnings beat and guidance raise underscore the profitability of Tenet's outpatient business, supporting a bullish outlook for the stock.

02

Market read

Tenet's strong earnings and guidance lift sentiment in the healthcare sector, especially for outpatient service providers.

03

What to watch

Potential downside from the non‑recurring Conifer EBITDA contribution ending and weaker ACA admissions.

Relevance 8/10Novelty 8/10Timing: post‑earnings reaction today

Background

Tenet Healthcare operates a large network of hospitals and over 500 ambulatory surgery centers, positioning it to benefit from shifting procedures to lower‑cost settings.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Tenet Healthcare reported Q3 earnings beat and raised full-year EBITDA guidance, driving a 40.8% price gain since April.

Expected impact

likely upward pressure as investors price in stronger earnings and guidance

Evidence & confidence

The beat was 42% above consensus and guidance was raised, indicating robust performance and improved cash flow.

Market effects

Highlights strength of outpatient surgery segment, potentially boosting related healthcare service stocks.

U.S. healthcare sector may see modest gains as investors rotate into outpatient-focused companies.

Limited to U.S. markets; no immediate global ripple.

Counterpoint

If the outpatient growth slows or wage inflation accelerates, the earnings boost may be temporary.

Key entities

  • Tenet Healthcare

    U.S. healthcare operator with a focus on ambulatory surgery centers.

Related articles

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.

$THCMed

High-acuity strategy helped Tenet weather surgery, uninsured headwinds in Q3

Tenet Healthcare raised its 2026 earnings guidance after its focus on high-acuity surgeries helped offset Q3 declines in procedure volumes. CEO Saum Sutaria cited the strategy's role in mitigating financial headwinds, including rising uninsured rates. Tenet expects full-year net income of $2.97B-$3.08B on revenues of $22.1B-$22.5B. Analysts noted Tenet's results were solid despite a challenging hospital sector.

$THCMedAI 8/10

Guggenheim lowers Tenet Healthcare stock price target on 2027 outlook

Guggenheim reduced its price target for Tenet Healthcare (NYSE:THC) to $306 from $307, maintaining a Buy rating. The firm cited a modestly revised 2027 EBITDA outlook. Tenet's Q3 2026 earnings beat estimates, with adjusted EPS of $6.64 vs. $4.67 and revenue of $5.63B vs. $5.49B. The stock trades at $270.57, with a P/E ratio of 10.36 and a free cash flow yield of 15%.